Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2007, Vol. 27 Issue (6): 56-60    DOI:
    
Micro-well protein array technology applied in monoclonal antibody isotyping
Download: HTML   PDF(557KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Monoclonal antibody isotyping micro–well protein array was designed and established. Twelve monoclonal antibodies and two polyclonal antibodies were isotyped by the isotyping protein array and ELISA respectively. The results showed that there was no difference between protein array method and ELISA in the application of isotyping monoclonal and polyclonal antibodies. And fewer sample and materials were used and the efficiency was improved in protein array method compared with ELISA. As a result, the antibody isotyping protein array could be used as a sensitive, rapid, directional and economical tool applying in high throughput monoclonal antibody generation.



Key wordsprotein array      monoclonal antibody      isotype     
Received: 01 February 2007      Published: 25 June 2007
Cite this article:

. Micro-well protein array technology applied in monoclonal antibody isotyping. China Biotechnology, 2007, 27(6): 56-60.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2007/V27/I6/56

[1] ZHAO Yan-shu,ZHANG Jin-hua,SONG Hao. Advances in Production of Monoclonal Antibody and Antibody Fragments in Engineered Prokaryotes and Yeast[J]. China Biotechnology, 2020, 40(8): 74-83.
[2] WANG Meng,SONG Hui-ru,CHENG Yu-jie,WANG Yi,YANG Bo,HU Zheng. Accurate Detection of Streptococcus pneumoniae by Using Ribosomal Protein L7 / L12 as Molecular Marker[J]. China Biotechnology, 2020, 40(4): 34-41.
[3] JIANG Yi-fan,JIA Yu,Wang Long,WANG Zhi-ming. The Glycosylation Design and Control of Monoclonal Antibody by Cell Culture[J]. China Biotechnology, 2019, 39(8): 95-103.
[4] LIU Guo-fang,LIU Xiao-zhi,GAO Jian,WANG Zhi-ming. Effects of Host Cell Residual Proteins on the Quality and Their Quality Control of Monoclonal Antibody[J]. China Biotechnology, 2019, 39(10): 105-110.
[5] Jian-wei REN,Jun LI,Shang-ze LI. Human CT55 Protein Prokaryotic Expression and Its Production of Monoclonal Antibody[J]. China Biotechnology, 2018, 38(11): 1-8.
[6] Kai-yun MAO,Yue-lei FAN,Heng-zhe WANG,Da-ming CHEN. Market Competition Pattern of Global PD-1/PD-L1 Monoclonal Antibody[J]. China Biotechnology, 2018, 38(11): 103-115.
[7] Jing-jing SUN,Wei-wei ZHOU,Lei-ming ZHOU,Qiao-hui ZHAO,Gui-lin LI. Advance in Large-Scale Culture of Hybridoma Cells in Vitro[J]. China Biotechnology, 2018, 38(10): 82-89.
[8] WANG Yun-long, ZHAO Er-xia, LI Yu-lin. Expression, Purification and Identification of Thymidine Kinase 1 Recombinant Protein[J]. China Biotechnology, 2017, 37(9): 15-22.
[9] WU Meng-ling, ZHOU Jia-wang, DU Jun. Development and Application of A Double Monoclonal Antibody Sandwich ELISA for the Assay of Nodal[J]. China Biotechnology, 2017, 37(3): 51-57.
[10] LI Min, WU Ri-wei. The Market Overview of Monoclonal Antibodies in Both Domestic and Abroad[J]. China Biotechnology, 2017, 37(3): 106-114.
[11] REN Hua-jing, LIU Xiao-zhi, WANG Zhi-ming, GAO Jian. Progression of Central Nervous System Disease Therapeutic Antibody Drug Application[J]. China Biotechnology, 2016, 36(9): 54-58.
[12] ZHANG Yin-chuan, LIU Meng-meng, ZHANG Ya-ting, GUI Fang, ZHANG Ai-hua, BI Lan, PAN Yong-bin. Construction and Screening of Recombinant Cell Line Expressing Fully-human mAbs against Human IgE[J]. China Biotechnology, 2015, 35(3): 66-74.
[13] WANG Lan, XIA Mao, GAO Kai. The Development and Quality Control of Antibody-Drug Conjugates[J]. China Biotechnology, 2014, 34(4): 85-94.
[14] GAO Kai, XU Zhi-kai, REN Yue-ming, WAN Lan, WANG Jun-zhi, GUO Zhong-ping. Points to Consider for the General Monograph of Monoclonal Antibody Based Biotherapeutics in Chinese Pharamacopeia[J]. China Biotechnology, 2014, 34(1): 127-134.
[15] LI Ming-zhu, HAN Wei-dong, Xing Guang-hui, TENG Zhen-lin, XUE Guo-mei, HOU Chen-rui, RUAN Hong-qiang, CHEN Wei. Research of N Terminal Sequencing Methods for Monoclonal Antibody Pharmaceuticals Blocked by Pyroglutamic Acid[J]. China Biotechnology, 2013, 33(8): 75-83.